FDA — authorised 15 December 2004
- Marketing authorisation holder: SUNOVION PHARMS INC
- Status: approved
FDA authorised Imovane on 15 December 2004
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 15 December 2004.
SUNOVION PHARMS INC holds the US marketing authorisation.